<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Quantitative brain <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy (MRS) and diffusion tensor imaging (DTI) were used to characterize one patient with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="15354">Choline</z:chebi> increases and N-acetylaspartate decreases were observed in pathologic frontal gray matter tissue compared to contralateral unaffected brain tissue without any change in the diffusion tensor imaging parameters (fractional anisotropy, apparent diffusion coefficient) </plain></SENT>
<SENT sid="2" pm="."><plain>The N-acetylaspartate decreases and/or <z:chebi fb="3" ids="15354">choline</z:chebi> increases observed here and in eight previously described Sturge-Weber patients probably reflect <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> or dysfunction and <z:hpo ids='HP_0011096'>demyelination</z:hpo> as a result of recurrent <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
</text></document>